SEC Form 4 · accession 0002014440-26-000012
Indivior Pharmaceuticals, Inc. · INDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Woodrow D Anderson
Officer — Chief Accounting Officer
Period of report
Aug 27, 2026
Accepted (ET)
Aug 27, 2026 · 4:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001625297
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 27, 2026 | P | 1,500 | $35.69 | A | 27,638 | D |
Table II — derivative securities
No Table II lines on this filing.